Marsha Shivley
Acute Care · Poplar Bluff, MONPI 1083705487
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations.
Across 66 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$269
- Alkermes, Inc.$182
- Otsuka America Pharmaceutical, Inc.$131
- Johnson & Johnson$122
- Braeburn Inc.$77
- GSK$52
- plus $372 from 17 others
What the payments were for
- Food & beverage$1,206100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $269 |
| Alkermes, Inc. | 9 | $182 |
| Otsuka America Pharmaceutical, Inc. | 7 | $131 |
| Johnson & Johnson | 6 | $122 |
| Braeburn Inc. | 4 | $77 |
| GSK | 4 | $52 |
| Amarin Pharma, Inc. | 3 | $43 |
| Novo Nordisk | 2 | $34 |
| Boehringer Ingelheim | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Amgen | 1 | $28 |
| Sanofi | 1 | $23 |
| Lundbeck LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| OWP Pharmaceuticals, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
How this compares
$1,206 in reported general payments places this provider in the 80th percentile of 272 acute care providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 30 | $15,939 |
| Aripiprazole | 42 | $3,492 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 79 | $2,993 |
| Oxcarbazepine | 43 | $1,660 |
| Olanzapine | 40 | $1,489 |
| Duloxetine Hcl | 114 | $1,400 |
| Buspirone Hcl | 80 | $875 |
| Lamotrigine | 53 | $564 |
| Quetiapine Fumarate | 46 | $523 |
| Mirtazapine | 55 | $509 |
| Prazosin Hcl | 37 | $482 |
| Doxepin Hcl | 21 | $383 |
| Bupropion Hcl SrBupropion Hcl | 36 | $337 |
| Gabapentin | 48 | $315 |
| Clonazepam | 38 | $301 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $18 | $15,93930 claims |
| Lilly USA, LLCOlanzapine | $12 | $1,48940 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 272 acute care providers in Missouri.
Other acute care in Poplar Bluff
- Molly CahillKansas City$22K
- Kristin PressChesterfield$14K
- Sarah HeaveyKansas City$9K
- Nedra HarringtonPotosi$8K
- Hunter SmithColumbia$7K
- Heather UelhofO Fallon$6K
- Caroline MundhenkeKansas City$6K
- Jennifer ReganSaint Louis$5K
- Jena SchollCape Girardeau$5K
- Kayla TourvilleSaint Louis$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.